BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22504456)

  • 1. A study of the functional significance of epidermal growth factor in major depressive disorder.
    Tian W; Zhang J; Zhang K; Yang H; Sun Y; Shen Y; Xu Q
    Psychiatr Genet; 2012 Aug; 22(4):161-7. PubMed ID: 22504456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor replication of candidate genes for major depressive disorder using genome-wide association data.
    Bosker FJ; Hartman CA; Nolte IM; Prins BP; Terpstra P; Posthuma D; van Veen T; Willemsen G; DeRijk RH; de Geus EJ; Hoogendijk WJ; Sullivan PF; Penninx BW; Boomsma DI; Snieder H; Nolen WA
    Mol Psychiatry; 2011 May; 16(5):516-32. PubMed ID: 20351714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder.
    Van Den Eede F; Venken T; Del-Favero J; Norrback KF; Souery D; Nilsson LG; Van den Bossche B; Hulstijn W; Sabbe BG; Cosyns P; Mendlewicz J; Adolfsson R; Van Broeckhoven C; Claes SJ
    Psychiatry Res; 2007 Sep; 153(1):17-25. PubMed ID: 17599466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of EGF, IGFBP-3 and TP53 Gene Polymorphisms with Major Depressive Disorder in Slovak Population.
    Mahmood S; Evinová A; Škereňová M; Ondrejka I; Lehotský J
    Cent Eur J Public Health; 2016 Sep; 24(3):223-230. PubMed ID: 27755861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett's esophagus and esophageal adenocarcinoma.
    Menke V; Pot RG; Moons LM; van Zoest KP; Hansen B; van Dekken H; Siersema PD; Kusters JG; Kuipers EJ
    J Hum Genet; 2012 Jan; 57(1):26-32. PubMed ID: 22129558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF promoter SNPs, plasma EGF levels and risk of breast cancer in Chinese women.
    Wang Y; Tian T; Hu Z; Tang J; Wang S; Wang X; Qin J; Huo X; Gao J; Ke Q; Jin G; Ma H; Wang X; Shen H
    Breast Cancer Res Treat; 2008 Sep; 111(2):321-7. PubMed ID: 17940864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
    Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
    Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperamental activity and epidermal growth factor A61G polymorphism in Finnish adults.
    Puttonen S; Keltikangas-Järvinen L; Elovainio M; Kivimäki M; Rontu R; Lehtimäki T
    Neuropsychobiology; 2007; 56(4):208-12. PubMed ID: 18382118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of cyclic adenosine monophosphate response element-binding protein gene and major depressive disorder].
    Liu XH; Xu YF; Cui DH; Jiang SD; Qian YP; Yu SY; Jiang KD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):263-6. PubMed ID: 20533262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C.
    Falleti E; Cmet S; Fabris C; Bitetto D; Cussigh A; Fornasiere E; Bignulin E; Feruglio C; Mosanghini E; Fontanini E; Pirisi M; Toniutto P
    Cytokine; 2012 Jan; 57(1):68-73. PubMed ID: 22122913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease.
    Araújo AP; Ribeiro R; Pinto D; Pereira D; Sousa B; Mauricio J; Lopes C; Medeiros R
    DNA Cell Biol; 2009 May; 28(5):265-9. PubMed ID: 19388850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Support for association between the Ser205Leu polymorphism of p75(NTR) and major depressive disorder.
    Fujii T; Yamamoto N; Hori H; Hattori K; Sasayama D; Teraishi T; Hashikura M; Tatsumi M; Okamoto N; Higuchi T; Kunugi H
    J Hum Genet; 2011 Nov; 56(11):806-9. PubMed ID: 21938001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association study between Protein Kinase C gamma gene polymorphism and major depressive disorder].
    Wang X; Sun Y; Sun N; Liu W; Lang XE; Yang R; Wu CS; Zhang KR
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(11):738-42. PubMed ID: 20627017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma.
    Gao LB; Wei YS; Zhou B; Wang YY; Liang WB; Li C; Li Y; Bai P; Fang WL; Xue H; Zhang L
    Cancer Genet Cytogenet; 2008 Sep; 185(2):69-73. PubMed ID: 18722874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder.
    Perlis RH; Purcell S; Fagerness J; Cusin C; Yamaki L; Fava M; Smoller JW
    Biol Psychiatry; 2007 Sep; 62(5):536-40. PubMed ID: 17300755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
    Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
    Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
    Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.